{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/nafis-neehal/CT-LLM/blob/main/CT_Experiment_04_04_24.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "VrFKt4EZ3gZD"
      },
      "source": [
        "## Installation and Imports"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "-Ejjrxpz3dZ_"
      },
      "outputs": [],
      "source": [
        "# !pip3 install nltk\n",
        "# !pip3 install evaluate\n",
        "# !pip3 install rouge-score\n",
        "# !pip3 install openai\n",
        "# !pip3 install langchain\n",
        "# !pip3 install requests\n",
        "# !pip3 install bert-score\n",
        "# !pip3 install langchain_openai\n",
        "# !pip3 install huggingface-hub"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "_E5iy83IRvG7"
      },
      "outputs": [],
      "source": [
        "import numpy as np\n",
        "import pandas as pd\n",
        "import requests\n",
        "import urllib.parse\n",
        "import json\n",
        "import os\n",
        "import requests\n",
        "from tqdm import tqdm\n",
        "\n",
        "# Import Colab Secrets userdata module\n",
        "from google.colab import userdata"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "## Helper Functions for Data Processing/Loading\n",
        "\n",
        "Selecting trials\n",
        "  - that matches the listed chronic conditions (chronic kidney disease, diabetes, obesity, cancer, hypertension)\n",
        "  - Interventional study only\n",
        "  - Trial is complete\n",
        "  - Has at least 6 or more reported baseline measures in clinicaltrials.gov portal\n",
        "\n",
        "Data extracted for each trial\n",
        "  - NCTId\n",
        "  - Brief Title\n",
        "  - Condition\n",
        "  - Brief Summary\n",
        "  - Eligibility Criteria\n",
        "  - Baseline MeasureTitle\n",
        "  - Primary Outcome Measure\n",
        "  - Intervention Name\n",
        "  - Study Type\n",
        "\n",
        "Total trials fetched - 1784\n",
        "\n",
        "Today's result on - 50 trials"
      ],
      "metadata": {
        "id": "2tzv15NwgOFn"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "def fetch_api_v2_data(condition, size):\n",
        "  '''\n",
        "  Fetches data from the Clinical Trials API v2.\n",
        "  condition: The condition to search for.\n",
        "  size: The number of maximum results to return for each condition.\n",
        "  return: A list of dictionaries (json format) containing the data for each condition.\n",
        "  '''\n",
        "\n",
        "  base_url = 'https://clinicaltrials.gov/api/v2/studies'\n",
        "\n",
        "  params = {\n",
        "      'query.cond': condition,\n",
        "      'pageSize' : size,\n",
        "      'filter.advanced': 'AREA[StudyType]INTERVENTIONAL | AREA[OverallStatus]COMPLETED | AREA[BaselineMeasure:size]RANGE[6,MAX]',\n",
        "      'fields': 'NCTId|BriefTitle|Condition|BriefSummary|EligibilityCriteria|BaselineMeasureTitle|PrimaryOutcomeMeasure|InterventionName|StudyType'\n",
        "  }\n",
        "\n",
        "  response = requests.get(base_url, params=params)\n",
        "\n",
        "  if response.status_code == 200:\n",
        "      # Process the response if successful\n",
        "      json_data = response.json()\n",
        "  else:\n",
        "      print(f\"Error fetching data, status code: {response.status_code}\")\n",
        "\n",
        "  return json_data\n",
        "\n"
      ],
      "metadata": {
        "id": "d6Bx8kC26-zY"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def extract_criteria(criteria_str):\n",
        "  '''\n",
        "  Extracts the inclusion and exclusion criteria from a string.\n",
        "  criteria_str: The string containing the criteria.\n",
        "  return: A tuple containing the inclusion and exclusion criteria.\n",
        "  '''\n",
        "\n",
        "  inclusion_start = criteria_str.find(\"Inclusion Criteria:\")\n",
        "  inclusion_end = criteria_str.find(\"Exclusion Criteria:\")\n",
        "  exclusion_start = inclusion_end + len(\"Exclusion Criteria:\")\n",
        "\n",
        "  inclusion_criteria = criteria_str[inclusion_start + len(\"Inclusion Criteria:\"):inclusion_end].strip()\n",
        "  exclusion_criteria = criteria_str[exclusion_start:].strip()\n",
        "\n",
        "  return inclusion_criteria, exclusion_criteria\n",
        "\n"
      ],
      "metadata": {
        "id": "ZuIkgBvMObaJ"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def parse_api_v2_data_to_df(data):\n",
        "\n",
        "  '''\n",
        "  Parses the data object returned from the Clinical Trials API v2, and converts it into a df.\n",
        "  data: A list of dictionaries (json format) containing the data for each condition, returned by the API.\n",
        "  return: A DataFrame containing the parsed data.\n",
        "  '''\n",
        "\n",
        "  # Create empty lists to store the extracted data\n",
        "  nct_ids = []\n",
        "  brief_titles = []\n",
        "  inclusion_criteria = []\n",
        "  exclusion_criteria = []\n",
        "  brief_summaries = []\n",
        "  conditions = []\n",
        "  study_types = []\n",
        "  interventions = []\n",
        "  primary_outcomes = []\n",
        "  measures = []\n",
        "\n",
        "  # Iterate over the list of studies\n",
        "  for study in data['studies']:\n",
        "      # Extract the relevant data\n",
        "      nct_ids.append(study['protocolSection']['identificationModule']['nctId'])\n",
        "      brief_titles.append(study['protocolSection']['identificationModule']['briefTitle'])\n",
        "      criteria = study['protocolSection']['eligibilityModule']['eligibilityCriteria']\n",
        "      incl_criteria, excl_criteria = extract_criteria(criteria)\n",
        "      incl_criteria = incl_criteria.strip()\n",
        "      excl_criteria = excl_criteria.strip()\n",
        "      inclusion_criteria.append(incl_criteria)\n",
        "      exclusion_criteria.append(excl_criteria)\n",
        "      brief_summaries.append(study['protocolSection']['descriptionModule']['briefSummary'])\n",
        "\n",
        "      # Extract the conditions\n",
        "      study_conditions = ''\n",
        "      for condition in study['protocolSection']['conditionsModule']['conditions']:\n",
        "          study_conditions += condition+ ', '\n",
        "      conditions.append(study_conditions)\n",
        "\n",
        "      # Extract the study type\n",
        "      study_types.append(study['protocolSection']['designModule']['studyType'])\n",
        "\n",
        "      # Extract the interventions\n",
        "      study_interventions = ''\n",
        "      for intervention in study['protocolSection']['armsInterventionsModule']['interventions']:\n",
        "          study_interventions += intervention['name'] + ', '\n",
        "      interventions.append(study_interventions)\n",
        "\n",
        "      # Extract the primary outcomes\n",
        "      study_primary_outcomes = ''\n",
        "      for outcome in study['protocolSection']['outcomesModule']['primaryOutcomes']:\n",
        "          study_primary_outcomes += outcome['measure'] + ', '\n",
        "      primary_outcomes.append(study_primary_outcomes)\n",
        "\n",
        "      # Extract the measures\n",
        "      study_measures = ''\n",
        "      for measure in study['resultsSection']['baselineCharacteristicsModule']['measures']:\n",
        "          study_measures += measure['title'] + ', '\n",
        "      measures.append(study_measures)\n",
        "\n",
        "  # Create a DataFrame from the extracted data\n",
        "  studies_df = pd.DataFrame({\n",
        "      'NCTId': nct_ids,\n",
        "      'BriefTitle': brief_titles,\n",
        "      'InclusionCriteria': inclusion_criteria,\n",
        "      'ExclusionCriteria': exclusion_criteria,\n",
        "      'BriefSummary': brief_summaries,\n",
        "      'Conditions': conditions,\n",
        "      'StudyType': study_types,\n",
        "      'Interventions': interventions,\n",
        "      'PrimaryOutcomes': primary_outcomes,\n",
        "      'BaselineMeasures': measures\n",
        "  })\n",
        "\n",
        "  # Save the DataFrame to a CSV file\n",
        "  #studies_df.to_csv('studies.csv', index=False)\n",
        "\n",
        "  return studies_df\n",
        "\n"
      ],
      "metadata": {
        "id": "YIj6Z4412rwI"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "final_df = pd.DataFrame()\n",
        "conditions = ['chronic kidney disease', 'diabetes', 'obesity', 'cancer', 'hypertension']\n",
        "for condition in conditions:\n",
        "  data = fetch_api_v2_data(condition, size=500)\n",
        "  df = parse_api_v2_data_to_df(data)\n",
        "  final_df = pd.concat([final_df, df], ignore_index=True)"
      ],
      "metadata": {
        "id": "QdSU1FnV-yia"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "final_df.shape"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "EQlXiqFDgkJs",
        "outputId": "efd227e1-49ed-4c0e-8602-0c1335922a6b"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "(1784, 10)"
            ]
          },
          "metadata": {},
          "execution_count": 7
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "final_df = final_df.sample(n=50, random_state=42, ignore_index=True)"
      ],
      "metadata": {
        "id": "wdnYilfie0Xj"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "final_df.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 4712
        },
        "id": "H-7y8y47f1Ec",
        "outputId": "9e1f131f-4527-4714-ab96-19d090e62c17"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "         NCTId                                         BriefTitle  \\\n",
              "0  NCT05803096  Self-Administered Nitrous Oxide (SANO) During ...   \n",
              "1  NCT02220894  Study of Pembrolizumab (MK-3475) Versus Platin...   \n",
              "2  NCT02128724       Palliative Thoracic Radiotherapy Plus BKM120   \n",
              "3  NCT03557658  Safety and Efficacy of Bexagliflozin in Subjec...   \n",
              "4  NCT01438476  Postoperative Thoracic Epidural Analgesia Vers...   \n",
              "\n",
              "                                   InclusionCriteria  \\\n",
              "0  * Biological male\\n* Aged 18 to 85 years\\n* Sc...   \n",
              "1  :\\n\\n* Histologically- or cytologically-confir...   \n",
              "2  * Evidence of histologically confirmed NSCLC o...   \n",
              "3  o meet the following criteria to be eligible f...   \n",
              "4  1. Patients undergoing liver and/or pancreatic...   \n",
              "\n",
              "                                   ExclusionCriteria  \\\n",
              "0  * Perioral facial hair impeding good mask seal...   \n",
              "1  :\\n\\n* Histologically- or cytologically-confir...   \n",
              "2  * Previous chemotherapy or biological therapy ...   \n",
              "3  o meet the following criteria to be eligible f...   \n",
              "4  1. Evidence of severe uncontrolled systemic di...   \n",
              "\n",
              "                                        BriefSummary  \\\n",
              "0  Transrectal prostate biopsy is a commonly perf...   \n",
              "1  In this study, participants with programmed ce...   \n",
              "2  This study will test whether a drug called BKM...   \n",
              "3  The purpose of this study is to examine the dr...   \n",
              "4  The goal of this clinical research study is to...   \n",
              "\n",
              "                                          Conditions       StudyType  \\\n",
              "0  Prostate Disease, Malignancy, Benign Prostatic...  INTERVENTIONAL   \n",
              "1                       Non-small Cell Lung Cancer,   INTERVENTIONAL   \n",
              "2                   Carcinoma, Non-Small-Cell Lung,   INTERVENTIONAL   \n",
              "3                          Type2 Diabetes Mellitus,   INTERVENTIONAL   \n",
              "4                  Liver Cancer, Pancreatic Cancer,   INTERVENTIONAL   \n",
              "\n",
              "                                       Interventions  \\\n",
              "0          Self-Administered Nitrous Oxide, Oxygen,    \n",
              "1  pembrolizumab, carboplatin, paclitaxel, pemetr...   \n",
              "2                                           BKM120,    \n",
              "3                                    Bexagliflozin,    \n",
              "4  Intravenous Patient-Controlled Analgesia (IVPC...   \n",
              "\n",
              "                                     PrimaryOutcomes  \\\n",
              "0  Post-biopsy Pain (VAS-P), Post-biopsy Anxiety ...   \n",
              "1  Overall Survival (OS) in Participants With a T...   \n",
              "2  Dose Escalation Analysis: Number of DLTs Obser...   \n",
              "3  Cmax (Maximum Observed Plasma Concentration), ...   \n",
              "4                    Postoperative Pain Experience,    \n",
              "\n",
              "                                    BaselineMeasures  \n",
              "0  Age, Continuous, Sex: Female, Male, Race/Ethni...  \n",
              "1  Age, Continuous, Sex: Female, Male, Race (NIH/...  \n",
              "2  Age, Continuous, Sex: Female, Male, Race and E...  \n",
              "3  Age, Continuous, Sex: Female, Male, Ethnicity ...  \n",
              "4  Age, Categorical, Age, Continuous, Sex: Female...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-06f7b692-ddb1-40c9-ac05-817f75a12983\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>NCTId</th>\n",
              "      <th>BriefTitle</th>\n",
              "      <th>InclusionCriteria</th>\n",
              "      <th>ExclusionCriteria</th>\n",
              "      <th>BriefSummary</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>StudyType</th>\n",
              "      <th>Interventions</th>\n",
              "      <th>PrimaryOutcomes</th>\n",
              "      <th>BaselineMeasures</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>NCT05803096</td>\n",
              "      <td>Self-Administered Nitrous Oxide (SANO) During ...</td>\n",
              "      <td>* Biological male\\n* Aged 18 to 85 years\\n* Sc...</td>\n",
              "      <td>* Perioral facial hair impeding good mask seal...</td>\n",
              "      <td>Transrectal prostate biopsy is a commonly perf...</td>\n",
              "      <td>Prostate Disease, Malignancy, Benign Prostatic...</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>Self-Administered Nitrous Oxide, Oxygen,</td>\n",
              "      <td>Post-biopsy Pain (VAS-P), Post-biopsy Anxiety ...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Race/Ethni...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>NCT02220894</td>\n",
              "      <td>Study of Pembrolizumab (MK-3475) Versus Platin...</td>\n",
              "      <td>:\\n\\n* Histologically- or cytologically-confir...</td>\n",
              "      <td>:\\n\\n* Histologically- or cytologically-confir...</td>\n",
              "      <td>In this study, participants with programmed ce...</td>\n",
              "      <td>Non-small Cell Lung Cancer,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>pembrolizumab, carboplatin, paclitaxel, pemetr...</td>\n",
              "      <td>Overall Survival (OS) in Participants With a T...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Race (NIH/...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>NCT02128724</td>\n",
              "      <td>Palliative Thoracic Radiotherapy Plus BKM120</td>\n",
              "      <td>* Evidence of histologically confirmed NSCLC o...</td>\n",
              "      <td>* Previous chemotherapy or biological therapy ...</td>\n",
              "      <td>This study will test whether a drug called BKM...</td>\n",
              "      <td>Carcinoma, Non-Small-Cell Lung,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>BKM120,</td>\n",
              "      <td>Dose Escalation Analysis: Number of DLTs Obser...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Race and E...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>NCT03557658</td>\n",
              "      <td>Safety and Efficacy of Bexagliflozin in Subjec...</td>\n",
              "      <td>o meet the following criteria to be eligible f...</td>\n",
              "      <td>o meet the following criteria to be eligible f...</td>\n",
              "      <td>The purpose of this study is to examine the dr...</td>\n",
              "      <td>Type2 Diabetes Mellitus,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>Bexagliflozin,</td>\n",
              "      <td>Cmax (Maximum Observed Plasma Concentration), ...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Ethnicity ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>NCT01438476</td>\n",
              "      <td>Postoperative Thoracic Epidural Analgesia Vers...</td>\n",
              "      <td>1. Patients undergoing liver and/or pancreatic...</td>\n",
              "      <td>1. Evidence of severe uncontrolled systemic di...</td>\n",
              "      <td>The goal of this clinical research study is to...</td>\n",
              "      <td>Liver Cancer, Pancreatic Cancer,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>Intravenous Patient-Controlled Analgesia (IVPC...</td>\n",
              "      <td>Postoperative Pain Experience,</td>\n",
              "      <td>Age, Categorical, Age, Continuous, Sex: Female...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-06f7b692-ddb1-40c9-ac05-817f75a12983')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-06f7b692-ddb1-40c9-ac05-817f75a12983 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-06f7b692-ddb1-40c9-ac05-817f75a12983');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-864a7900-1e32-415f-a6fc-363895856318\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-864a7900-1e32-415f-a6fc-363895856318')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-864a7900-1e32-415f-a6fc-363895856318 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "final_df",
              "summary": "{\n  \"name\": \"final_df\",\n  \"rows\": 50,\n  \"fields\": [\n    {\n      \"column\": \"NCTId\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"NCT01560637\",\n          \"NCT01186939\",\n          \"NCT01552694\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BriefTitle\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension\",\n          \"An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS)\",\n          \"Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"InclusionCriteria\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"* Participated in United Therapeutics Study TDE-PH-310\\n* All women of childbearing potential (WOCBP) must have practiced true abstinence from intercourse when it was in line with their preferred and usual lifestyle or used 2 different forms of highly effective contraception for the duration of the study and for at least 30 days after discontinuing study medication.\\n* Males who participated in the study must have used a condom during the length of the study and for at least 48 hours after their last dose of study medication.\",\n          \"* Participants were considered eligible if they had been randomized to azacitidine treatment in the primary study and were receiving azacitidine at the time of study closure, had completed 12 months of treatment and observation in the primary study, and had signed the informed consent document for the extension phase of the study.\\n* See study: AZA PH GL 2003 CL 001 for a list of inclusion criteria for the primary study.\",\n          \"* 18-65 yr old HIV infected men and women.\\n* Stable (at least the past 6 months) on combined antiretroviral therapy (cART).\\n* Stable immune (\\\\> 300 CD4+ T-cells/\\u00b5L) and virologic (\\\\< 50 copies HIV RNA/mL) status.\\n* Insulin resistant/impaired glucose tolerance (fasting glucose 100-125mg/dL, or 2-hr glucose 140-200mg/dL or fasting HOMA-IR= 2.5-6.0).\\n* Waist circumference \\\\> 102 cm (men), \\\\> 88 cm (women).\\n* BMI \\\\> 20 kg/m2.\\n* Fasting hypertriglyceridemia \\\\> 150 mg/dL.\\n* Low HDL-cholesterol (\\\\< 40 mg/dL in men or \\\\< 50 mg/dL in women).\\n* Platelet count \\\\> 30,000/mm3.\\n* Absolute neutrophil count \\\\> 750/mm3.\\n* Transaminases \\\\< 2.5x the upper limit of normal.\\n* Long-term non-progressors (not taking anti-HIV medications) are not eligible.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"ExclusionCriteria\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"* The subject was pregnant or lactating.\\n* The subject had received infused or inhaled prostacyclin therapy for 29 days or more.\\n* The subject was prematurely discontinued from TDE-PH-310 for reasons other than a clinical worsening event.\\n* The subject developed a concurrent illness or condition during the conduct of TDE-PH-310 which, in the opinion of the Investigator, would represent a risk to their overall health if they enrolled in this study.\",\n          \"* None specific to the extension phase of the study\\n* See study: AZA PH GL 2003 CL 001 for a list of exclusion criteria for the primary study.\",\n          \"* Diabetes (T2DM, IDDM or diabetic ketoacidosis) or taking any glucose-lowering medication (e.g., insulin, TZDs, metformin, sulfonylurea).\\n* Any agent that might artifactually alter glycemic control (e.g., glucocorticoids, megace, rhGH, GH-secretagogue, testosterone derivatives, creatine monohydrate, chromium picolinate, AA/protein supplements, medium- or long-chain fatty acids) during 6 months prior to or during enrollment.\\n* History of serious CV disease. NYHA Functional Class III or IV (e.g., recent MI, unstable angina, edema, CHF, CAD, CABG, stroke, resting hypertension \\\\> 160/95 mmHg), irregular heart rhythm, resting ST-segment depression \\\\> 1mm). Treatment with medications for CV condition (e.g., \\u03b1- or \\u00df-blockers). Some BP-lowering medications (Ca++channel blocker, diuretic, or ACE inhibitor) are permitted.\\n* Moderate to severe renal insufficiency. Serum creatinine \\\\> 1.7 mg/dL (men) \\\\> 1.5 mg/dL (women).\\n* Plan or anticipate a change in anti-HIV medications during the study.\\n* Lipid-lowering medications are permitted (fibrate or statin or niacin), but must be stable on that agent for at least 6 months prior to enrollment. Lipid-lowering agents cannot be started during the treatment period.\\n* Chronic hepatitis B (HBV-surface antigen positive). Active hepatitis C (detectable Hep C RNA).\\n* Positive urine drug test for opiates, methamphetamine, heroin, cocaine. Active substance abuse that the MD-scientist believes may compromise safety, compliance, interfere with study drug or data interpretation.\\n* Hematocrit \\\\< 34% in men or \\\\< 25% in women with symptoms (fatigue, \\\"tired-legs\\\", shortness of breath). Hemoglobin \\\\< 10 gm/dL with symptoms.\\n* Pregnant or nursing mothers. Women must agree to use an acceptable form of birth control during the study. If using birth control pills-must be stable on this medication for at least 6 months prior to enrollment.\\n* Active malignancy or treatment with chemotherapeutic agents or radiation therapy or any cytokine or anti-cytokine therapy during 6 months prior to enrollment.\\n* History of pancreatitis\\n* \\\\> 10% unintentional weight loss during the 6 months prior to enrollment.\\n* Reduced cognitive function/unable to provide voluntary informed consent. Prisoners are excluded.\\n* Blinded investigational drugs for 3 months prior to enrollment that will not be unblinded before enrollment.\\n* Nausea, vomiting, diarrhea (\\\\> 4 loose stools/day) that are unresponsive to treatment.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BriefSummary\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"This study is an international, multi-center, open-label study designed to provide oral treprostinil (UT-15C) to eligible subjects with pulmonary arterial hypertension who have completed the TDE-PH-310 study. The purpose of this study is to assess the long-term safety of UT-15C and to assess the effects of long-term treatment with UT-15C on exercise capacity.\",\n          \"At the conclusion of study AZA PH GL 2003 CL 001 (NCT00071799), eligible participants could be enrolled in an optional extension phase in order to continue treatment with azacitidine until it became commercially available; the continued treatment was for ethical and safety reasons only and not to provide additional efficacy data.\",\n          \"People living with human immunodeficiency virus infection (HIV) have 2-4fold greater risk for developing diabetes and heart disease than the general population. They need safe and effective treatments that reduce the risk for developing diabetes and heart disease, and improve their quality of life. This project will explore whether a new anti-diabetes medication (Januvia) with a novel mechanism of action reduces inflammation, and improves blood vessel function in HIV infected men and women with several risk factors for developing cardiovascular disease.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Conditions\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 48,\n        \"samples\": [\n          \"Metabolic Syndrome X, \",\n          \"Type 2 Diabetes Mellitus, \",\n          \"Hypertension, Hyperlipidemia, Diabetes, \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"StudyType\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"INTERVENTIONAL\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Interventions\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"UT-15C (treprostinil diolamine), \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"PrimaryOutcomes\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"Number of Adverse Events, \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BaselineMeasures\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 46,\n        \"samples\": [\n          \"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, BMI, Arterial hypertension (AH) duration, Hypertension grade, Chronic heart failure (CHF) NYHA Class I, Prior therapy for arterial hypertension, Smoking history, Alcohol history, \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 9
        }
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "lC36RmzKpMZV"
      },
      "source": [
        "## Run GPT Models for generating list of baseline measures\n",
        "\n",
        "\n",
        "\n",
        "*   GPT 4-turbo-preview (Dec 2023 / Latest / ~4s per iteration)\n",
        "*   GPT 3.5-turbo (Sept 2021 / 3x faster inference !!!)\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "PGw6a66no4Wn"
      },
      "outputs": [],
      "source": [
        "from langchain_core.messages import HumanMessage, SystemMessage\n",
        "from langchain_core.prompts.chat import (\n",
        "    ChatPromptTemplate,\n",
        "    HumanMessagePromptTemplate,\n",
        "    SystemMessagePromptTemplate,\n",
        ")\n",
        "from langchain_openai import ChatOpenAI\n",
        "from langchain_community.llms import HuggingFaceEndpoint\n",
        "\n",
        "os.environ[\"OPENAI_API_KEY\"] = userdata.get(\"OPENAI_KEY_BS1\")\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ftIZnrWIp5lL"
      },
      "outputs": [],
      "source": [
        "def generate_openai_prompt_template():\n",
        "\n",
        "    system_template = (\n",
        "        \"You are a helpful assistant and expert in clinical domain and clinical trial design. Answer the question based on the context below and your knowledge on clinical trials and clinical domain\"\n",
        "    )\n",
        "\n",
        "    system_message_prompt = SystemMessagePromptTemplate.from_template(system_template)\n",
        "\n",
        "    human_template = \"\"\"\n",
        "\n",
        "    Context:\n",
        "    {trial_info}\n",
        "\n",
        "    Question:\n",
        "    {query}\n",
        "\n",
        "    Answer:\n",
        "\n",
        "    \"\"\"\n",
        "\n",
        "    human_message_prompt = HumanMessagePromptTemplate.from_template(human_template)\n",
        "\n",
        "    chat_prompt = ChatPromptTemplate.from_messages(\n",
        "        [system_message_prompt, human_message_prompt]\n",
        "    )\n",
        "\n",
        "    return chat_prompt\n"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "def single_openai_prompt(row, chat_prompt):\n",
        "\n",
        "  '''\n",
        "  Actual Prompt Structured in LangChain Prompt Template\n",
        "  {Instruction} {Trial Context} {Question} -> {Answer}\n",
        "  '''\n",
        "\n",
        "  title = row['BriefTitle']\n",
        "  brief_summary = row['BriefSummary']\n",
        "  condition = row['Conditions']\n",
        "  intervention = row['Interventions']\n",
        "  outcome = row['PrimaryOutcomes']\n",
        "\n",
        "  trial_info = f\"Title- {title}\\nBrief Summary- {brief_summary}\\nCondition- {condition}\\nIntervention- {intervention}\\nOutcome- {outcome}\"\n",
        "  query = \"Return a list of probable baseline features (seperated by comma, without itemizing or bullet points) that needs to\\\n",
        "  be measured before the trial starts and in each follow up visits. These baseline\\\n",
        "  features are usually found in Table 1 of a trial related publications. Don't give any additional explanations.\"\n",
        "\n",
        "  prompt = chat_prompt.format_prompt(\n",
        "      trial_info=trial_info, query=query\n",
        "  ).to_messages()\n",
        "\n",
        "  return prompt\n",
        "\n",
        "def run_single_openai_query(row, chat_prompt, chat, ret_prompt=False):\n",
        "\n",
        "  prompt = single_openai_prompt(row, chat_prompt)\n",
        "\n",
        "  ret = chat.invoke(\n",
        "    prompt\n",
        "  )\n",
        "\n",
        "  if ret_prompt:\n",
        "    return [ret.content, prompt]\n",
        "\n",
        "  return ret.content"
      ],
      "metadata": {
        "id": "vyTMP10yI9o6"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "vWNaC_MC-qQH"
      },
      "outputs": [],
      "source": [
        "def run_openai_loop(df, model):\n",
        "\n",
        "  # initialize the models\n",
        "  model_name = model\n",
        "  chat_llm = ChatOpenAI(model_name=model_name, temperature=0)\n",
        "  chat_prompt = generate_openai_prompt_template()\n",
        "\n",
        "  for idx, row in tqdm(final_df.iterrows()):\n",
        "    response = run_single_openai_query(row, chat_prompt, chat_llm)\n",
        "    df.loc[idx, model_name] = response\n",
        "    if idx % 10 == 0:\n",
        "      print(f\"\\nProcessed {idx} rows\")\n",
        "\n",
        "  return df"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "response_df = run_openai_loop(final_df.copy(), model = \"gpt-3.5-turbo\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "sL4hUr64Ouls",
        "outputId": "1bc67b37-f78f-48ea-97fe-d839a1f3a8a7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "1it [00:01,  1.35s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 0 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "11it [00:11,  1.02s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 10 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "21it [00:22,  1.21s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 20 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "31it [00:35,  1.19s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 30 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "41it [00:44,  1.08it/s]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 40 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "50it [00:53,  1.07s/it]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "response_df = run_openai_loop(response_df.copy(), model = \"gpt-4-0125-preview\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "89dJkq51f-_s",
        "outputId": "3bbb4669-6cf4-44db-a16c-4eef74b4920a"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "1it [00:05,  5.32s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 0 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "11it [01:02,  5.79s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 10 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "21it [01:47,  4.26s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 20 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "31it [02:37,  5.12s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 30 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "41it [03:21,  4.83s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 40 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "50it [04:01,  4.83s/it]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "response_df.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 501
        },
        "id": "g_Wha3C5PxTI",
        "outputId": "76303c12-65d7-499c-94d8-fc0e52301fd2"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "         NCTId                                         BriefTitle  \\\n",
              "0  NCT05803096  Self-Administered Nitrous Oxide (SANO) During ...   \n",
              "1  NCT02220894  Study of Pembrolizumab (MK-3475) Versus Platin...   \n",
              "2  NCT02128724       Palliative Thoracic Radiotherapy Plus BKM120   \n",
              "3  NCT03557658  Safety and Efficacy of Bexagliflozin in Subjec...   \n",
              "4  NCT01438476  Postoperative Thoracic Epidural Analgesia Vers...   \n",
              "\n",
              "                                   InclusionCriteria  \\\n",
              "0  * Biological male\\n* Aged 18 to 85 years\\n* Sc...   \n",
              "1  :\\n\\n* Histologically- or cytologically-confir...   \n",
              "2  * Evidence of histologically confirmed NSCLC o...   \n",
              "3  o meet the following criteria to be eligible f...   \n",
              "4  1. Patients undergoing liver and/or pancreatic...   \n",
              "\n",
              "                                   ExclusionCriteria  \\\n",
              "0  * Perioral facial hair impeding good mask seal...   \n",
              "1  :\\n\\n* Histologically- or cytologically-confir...   \n",
              "2  * Previous chemotherapy or biological therapy ...   \n",
              "3  o meet the following criteria to be eligible f...   \n",
              "4  1. Evidence of severe uncontrolled systemic di...   \n",
              "\n",
              "                                        BriefSummary  \\\n",
              "0  Transrectal prostate biopsy is a commonly perf...   \n",
              "1  In this study, participants with programmed ce...   \n",
              "2  This study will test whether a drug called BKM...   \n",
              "3  The purpose of this study is to examine the dr...   \n",
              "4  The goal of this clinical research study is to...   \n",
              "\n",
              "                                          Conditions       StudyType  \\\n",
              "0  Prostate Disease, Malignancy, Benign Prostatic...  INTERVENTIONAL   \n",
              "1                       Non-small Cell Lung Cancer,   INTERVENTIONAL   \n",
              "2                   Carcinoma, Non-Small-Cell Lung,   INTERVENTIONAL   \n",
              "3                          Type2 Diabetes Mellitus,   INTERVENTIONAL   \n",
              "4                  Liver Cancer, Pancreatic Cancer,   INTERVENTIONAL   \n",
              "\n",
              "                                       Interventions  \\\n",
              "0          Self-Administered Nitrous Oxide, Oxygen,    \n",
              "1  pembrolizumab, carboplatin, paclitaxel, pemetr...   \n",
              "2                                           BKM120,    \n",
              "3                                    Bexagliflozin,    \n",
              "4  Intravenous Patient-Controlled Analgesia (IVPC...   \n",
              "\n",
              "                                     PrimaryOutcomes  \\\n",
              "0  Post-biopsy Pain (VAS-P), Post-biopsy Anxiety ...   \n",
              "1  Overall Survival (OS) in Participants With a T...   \n",
              "2  Dose Escalation Analysis: Number of DLTs Obser...   \n",
              "3  Cmax (Maximum Observed Plasma Concentration), ...   \n",
              "4                    Postoperative Pain Experience,    \n",
              "\n",
              "                                    BaselineMeasures  \\\n",
              "0  Age, Continuous, Sex: Female, Male, Race/Ethni...   \n",
              "1  Age, Continuous, Sex: Female, Male, Race (NIH/...   \n",
              "2  Age, Continuous, Sex: Female, Male, Race and E...   \n",
              "3  Age, Continuous, Sex: Female, Male, Ethnicity ...   \n",
              "4  Age, Categorical, Age, Continuous, Sex: Female...   \n",
              "\n",
              "                                       gpt-3.5-turbo  \\\n",
              "0  Age, Gender, Body Mass Index (BMI), Previous h...   \n",
              "1  Age, Gender, Race, ECOG Performance Status, Sm...   \n",
              "2  Age, Gender, Smoking history, Performance stat...   \n",
              "3  Age, Gender, Weight, Height, BMI, Blood Pressu...   \n",
              "4  Age, Gender, Body Mass Index, Smoking Status, ...   \n",
              "\n",
              "                                  gpt-4-0125-preview  \n",
              "0  Age, gender, race/ethnicity, body mass index (...  \n",
              "1  Age, sex, race/ethnicity, smoking history, Eas...  \n",
              "2  Age, sex, race/ethnicity, smoking history, per...  \n",
              "3  Age, sex, body mass index (BMI), duration of T...  \n",
              "4  Age, sex, body mass index (BMI), type of surge...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-6989fb60-23d1-4a7f-957e-0f87382af25e\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>NCTId</th>\n",
              "      <th>BriefTitle</th>\n",
              "      <th>InclusionCriteria</th>\n",
              "      <th>ExclusionCriteria</th>\n",
              "      <th>BriefSummary</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>StudyType</th>\n",
              "      <th>Interventions</th>\n",
              "      <th>PrimaryOutcomes</th>\n",
              "      <th>BaselineMeasures</th>\n",
              "      <th>gpt-3.5-turbo</th>\n",
              "      <th>gpt-4-0125-preview</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>NCT05803096</td>\n",
              "      <td>Self-Administered Nitrous Oxide (SANO) During ...</td>\n",
              "      <td>* Biological male\\n* Aged 18 to 85 years\\n* Sc...</td>\n",
              "      <td>* Perioral facial hair impeding good mask seal...</td>\n",
              "      <td>Transrectal prostate biopsy is a commonly perf...</td>\n",
              "      <td>Prostate Disease, Malignancy, Benign Prostatic...</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>Self-Administered Nitrous Oxide, Oxygen,</td>\n",
              "      <td>Post-biopsy Pain (VAS-P), Post-biopsy Anxiety ...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Race/Ethni...</td>\n",
              "      <td>Age, Gender, Body Mass Index (BMI), Previous h...</td>\n",
              "      <td>Age, gender, race/ethnicity, body mass index (...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>NCT02220894</td>\n",
              "      <td>Study of Pembrolizumab (MK-3475) Versus Platin...</td>\n",
              "      <td>:\\n\\n* Histologically- or cytologically-confir...</td>\n",
              "      <td>:\\n\\n* Histologically- or cytologically-confir...</td>\n",
              "      <td>In this study, participants with programmed ce...</td>\n",
              "      <td>Non-small Cell Lung Cancer,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>pembrolizumab, carboplatin, paclitaxel, pemetr...</td>\n",
              "      <td>Overall Survival (OS) in Participants With a T...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Race (NIH/...</td>\n",
              "      <td>Age, Gender, Race, ECOG Performance Status, Sm...</td>\n",
              "      <td>Age, sex, race/ethnicity, smoking history, Eas...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>NCT02128724</td>\n",
              "      <td>Palliative Thoracic Radiotherapy Plus BKM120</td>\n",
              "      <td>* Evidence of histologically confirmed NSCLC o...</td>\n",
              "      <td>* Previous chemotherapy or biological therapy ...</td>\n",
              "      <td>This study will test whether a drug called BKM...</td>\n",
              "      <td>Carcinoma, Non-Small-Cell Lung,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>BKM120,</td>\n",
              "      <td>Dose Escalation Analysis: Number of DLTs Obser...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Race and E...</td>\n",
              "      <td>Age, Gender, Smoking history, Performance stat...</td>\n",
              "      <td>Age, sex, race/ethnicity, smoking history, per...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>NCT03557658</td>\n",
              "      <td>Safety and Efficacy of Bexagliflozin in Subjec...</td>\n",
              "      <td>o meet the following criteria to be eligible f...</td>\n",
              "      <td>o meet the following criteria to be eligible f...</td>\n",
              "      <td>The purpose of this study is to examine the dr...</td>\n",
              "      <td>Type2 Diabetes Mellitus,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>Bexagliflozin,</td>\n",
              "      <td>Cmax (Maximum Observed Plasma Concentration), ...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Ethnicity ...</td>\n",
              "      <td>Age, Gender, Weight, Height, BMI, Blood Pressu...</td>\n",
              "      <td>Age, sex, body mass index (BMI), duration of T...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>NCT01438476</td>\n",
              "      <td>Postoperative Thoracic Epidural Analgesia Vers...</td>\n",
              "      <td>1. Patients undergoing liver and/or pancreatic...</td>\n",
              "      <td>1. Evidence of severe uncontrolled systemic di...</td>\n",
              "      <td>The goal of this clinical research study is to...</td>\n",
              "      <td>Liver Cancer, Pancreatic Cancer,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>Intravenous Patient-Controlled Analgesia (IVPC...</td>\n",
              "      <td>Postoperative Pain Experience,</td>\n",
              "      <td>Age, Categorical, Age, Continuous, Sex: Female...</td>\n",
              "      <td>Age, Gender, Body Mass Index, Smoking Status, ...</td>\n",
              "      <td>Age, sex, body mass index (BMI), type of surge...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-6989fb60-23d1-4a7f-957e-0f87382af25e')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-6989fb60-23d1-4a7f-957e-0f87382af25e button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-6989fb60-23d1-4a7f-957e-0f87382af25e');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-768ce693-f256-41db-80c3-73cb1789cb4c\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-768ce693-f256-41db-80c3-73cb1789cb4c')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-768ce693-f256-41db-80c3-73cb1789cb4c button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "response_df",
              "summary": "{\n  \"name\": \"response_df\",\n  \"rows\": 50,\n  \"fields\": [\n    {\n      \"column\": \"NCTId\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"NCT01560637\",\n          \"NCT01186939\",\n          \"NCT01552694\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BriefTitle\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension\",\n          \"An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS)\",\n          \"Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"InclusionCriteria\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"* Participated in United Therapeutics Study TDE-PH-310\\n* All women of childbearing potential (WOCBP) must have practiced true abstinence from intercourse when it was in line with their preferred and usual lifestyle or used 2 different forms of highly effective contraception for the duration of the study and for at least 30 days after discontinuing study medication.\\n* Males who participated in the study must have used a condom during the length of the study and for at least 48 hours after their last dose of study medication.\",\n          \"* Participants were considered eligible if they had been randomized to azacitidine treatment in the primary study and were receiving azacitidine at the time of study closure, had completed 12 months of treatment and observation in the primary study, and had signed the informed consent document for the extension phase of the study.\\n* See study: AZA PH GL 2003 CL 001 for a list of inclusion criteria for the primary study.\",\n          \"* 18-65 yr old HIV infected men and women.\\n* Stable (at least the past 6 months) on combined antiretroviral therapy (cART).\\n* Stable immune (\\\\> 300 CD4+ T-cells/\\u00b5L) and virologic (\\\\< 50 copies HIV RNA/mL) status.\\n* Insulin resistant/impaired glucose tolerance (fasting glucose 100-125mg/dL, or 2-hr glucose 140-200mg/dL or fasting HOMA-IR= 2.5-6.0).\\n* Waist circumference \\\\> 102 cm (men), \\\\> 88 cm (women).\\n* BMI \\\\> 20 kg/m2.\\n* Fasting hypertriglyceridemia \\\\> 150 mg/dL.\\n* Low HDL-cholesterol (\\\\< 40 mg/dL in men or \\\\< 50 mg/dL in women).\\n* Platelet count \\\\> 30,000/mm3.\\n* Absolute neutrophil count \\\\> 750/mm3.\\n* Transaminases \\\\< 2.5x the upper limit of normal.\\n* Long-term non-progressors (not taking anti-HIV medications) are not eligible.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"ExclusionCriteria\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"* The subject was pregnant or lactating.\\n* The subject had received infused or inhaled prostacyclin therapy for 29 days or more.\\n* The subject was prematurely discontinued from TDE-PH-310 for reasons other than a clinical worsening event.\\n* The subject developed a concurrent illness or condition during the conduct of TDE-PH-310 which, in the opinion of the Investigator, would represent a risk to their overall health if they enrolled in this study.\",\n          \"* None specific to the extension phase of the study\\n* See study: AZA PH GL 2003 CL 001 for a list of exclusion criteria for the primary study.\",\n          \"* Diabetes (T2DM, IDDM or diabetic ketoacidosis) or taking any glucose-lowering medication (e.g., insulin, TZDs, metformin, sulfonylurea).\\n* Any agent that might artifactually alter glycemic control (e.g., glucocorticoids, megace, rhGH, GH-secretagogue, testosterone derivatives, creatine monohydrate, chromium picolinate, AA/protein supplements, medium- or long-chain fatty acids) during 6 months prior to or during enrollment.\\n* History of serious CV disease. NYHA Functional Class III or IV (e.g., recent MI, unstable angina, edema, CHF, CAD, CABG, stroke, resting hypertension \\\\> 160/95 mmHg), irregular heart rhythm, resting ST-segment depression \\\\> 1mm). Treatment with medications for CV condition (e.g., \\u03b1- or \\u00df-blockers). Some BP-lowering medications (Ca++channel blocker, diuretic, or ACE inhibitor) are permitted.\\n* Moderate to severe renal insufficiency. Serum creatinine \\\\> 1.7 mg/dL (men) \\\\> 1.5 mg/dL (women).\\n* Plan or anticipate a change in anti-HIV medications during the study.\\n* Lipid-lowering medications are permitted (fibrate or statin or niacin), but must be stable on that agent for at least 6 months prior to enrollment. Lipid-lowering agents cannot be started during the treatment period.\\n* Chronic hepatitis B (HBV-surface antigen positive). Active hepatitis C (detectable Hep C RNA).\\n* Positive urine drug test for opiates, methamphetamine, heroin, cocaine. Active substance abuse that the MD-scientist believes may compromise safety, compliance, interfere with study drug or data interpretation.\\n* Hematocrit \\\\< 34% in men or \\\\< 25% in women with symptoms (fatigue, \\\"tired-legs\\\", shortness of breath). Hemoglobin \\\\< 10 gm/dL with symptoms.\\n* Pregnant or nursing mothers. Women must agree to use an acceptable form of birth control during the study. If using birth control pills-must be stable on this medication for at least 6 months prior to enrollment.\\n* Active malignancy or treatment with chemotherapeutic agents or radiation therapy or any cytokine or anti-cytokine therapy during 6 months prior to enrollment.\\n* History of pancreatitis\\n* \\\\> 10% unintentional weight loss during the 6 months prior to enrollment.\\n* Reduced cognitive function/unable to provide voluntary informed consent. Prisoners are excluded.\\n* Blinded investigational drugs for 3 months prior to enrollment that will not be unblinded before enrollment.\\n* Nausea, vomiting, diarrhea (\\\\> 4 loose stools/day) that are unresponsive to treatment.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BriefSummary\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"This study is an international, multi-center, open-label study designed to provide oral treprostinil (UT-15C) to eligible subjects with pulmonary arterial hypertension who have completed the TDE-PH-310 study. The purpose of this study is to assess the long-term safety of UT-15C and to assess the effects of long-term treatment with UT-15C on exercise capacity.\",\n          \"At the conclusion of study AZA PH GL 2003 CL 001 (NCT00071799), eligible participants could be enrolled in an optional extension phase in order to continue treatment with azacitidine until it became commercially available; the continued treatment was for ethical and safety reasons only and not to provide additional efficacy data.\",\n          \"People living with human immunodeficiency virus infection (HIV) have 2-4fold greater risk for developing diabetes and heart disease than the general population. They need safe and effective treatments that reduce the risk for developing diabetes and heart disease, and improve their quality of life. This project will explore whether a new anti-diabetes medication (Januvia) with a novel mechanism of action reduces inflammation, and improves blood vessel function in HIV infected men and women with several risk factors for developing cardiovascular disease.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Conditions\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 48,\n        \"samples\": [\n          \"Metabolic Syndrome X, \",\n          \"Type 2 Diabetes Mellitus, \",\n          \"Hypertension, Hyperlipidemia, Diabetes, \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"StudyType\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"INTERVENTIONAL\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Interventions\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"UT-15C (treprostinil diolamine), \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"PrimaryOutcomes\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"Number of Adverse Events, \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BaselineMeasures\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 46,\n        \"samples\": [\n          \"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, BMI, Arterial hypertension (AH) duration, Hypertension grade, Chronic heart failure (CHF) NYHA Class I, Prior therapy for arterial hypertension, Smoking history, Alcohol history, \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"gpt-3.5-turbo\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"Age, Gender, Weight, Height, Body Mass Index, Pulmonary Arterial Hypertension Functional Class, Six-Minute Walk Distance, Borg Dyspnea Score, Hemodynamics (e.g., Right Atrial Pressure, Cardiac Output), World Health Organization Functional Class, Use of Concomitant Medications\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"gpt-4-0125-preview\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"Age, sex, race, body mass index (BMI), baseline 6-minute walk distance (6MWD), World Health Organization (WHO) functional class, duration of pulmonary arterial hypertension, prior pulmonary arterial hypertension therapy, right heart catheterization parameters (mean pulmonary artery pressure, pulmonary vascular resistance, cardiac output), echocardiographic parameters (right ventricular size and function, tricuspid annular plane systolic excursion), N-terminal pro b-type natriuretic peptide (NT-proBNP) levels, liver function tests, renal function tests, hemoglobin levels, platelet count\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 63
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# RUN Open-Source HF Models\n",
        "\n",
        "\n",
        "\n",
        "*   mistralai/Mistral-7B-Instruct-v0.2\n",
        "\n"
      ],
      "metadata": {
        "id": "LC1qW9dnT68Q"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "from langchain.chains import LLMChain\n",
        "from langchain.prompts import PromptTemplate\n",
        "from langchain_community.llms import HuggingFaceEndpoint\n",
        "\n",
        "os.environ[\"HUGGINGFACEHUB_API_TOKEN\"] = userdata.get(\"HF_TOKEN\")"
      ],
      "metadata": {
        "id": "amCaZ9haUfZw"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def generate_hf_prompt_template():\n",
        "  system_template = \"\"\"\n",
        "  You are a helpful assistant and expert in clinical domain and clinical trial design.\\\n",
        "  Answer the question based on the context below and your\\\n",
        "  knowledge on clinical trials and clinical domain\n",
        "  \"\"\"\n",
        "\n",
        "  human_template = \"\"\"\n",
        "  Context:\n",
        "  {trial_info}\n",
        "\n",
        "  Question:\n",
        "  {query}\n",
        "\n",
        "  Answer:\n",
        "  \"\"\"\n",
        "\n",
        "  prompt = PromptTemplate.from_template(system_template + human_template)\n",
        "\n",
        "  return prompt"
      ],
      "metadata": {
        "id": "uHNh19-oT7Dv"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def run_single_HF_query(row, prompt, llm):\n",
        "  '''\n",
        "  Actual Prompt Structured in LangChain Prompt Template\n",
        "  {Instruction} {Context} {Question} -> {Answer}\n",
        "  '''\n",
        "\n",
        "  title = row['BriefTitle']\n",
        "  brief_summary = row['BriefSummary']\n",
        "  condition = row['Conditions']\n",
        "  intervention = row['Interventions']\n",
        "  outcome = row['PrimaryOutcomes']\n",
        "\n",
        "  trial_info = f\"Title- {title}\\nBrief Summary- {brief_summary}\\nCondition- {condition}\\nIntervention- {intervention}\\nOutcome- {outcome}\"\n",
        "  query = \"Return a list of probable baseline features (seperated by comma, without itemizing or bullet points) that needs to\\\n",
        "  be measured before the trial starts and in each follow up visits. These baseline\\\n",
        "  features are usually found in Table 1 of a trial related publications. Don't give any additional explanations.\"\n",
        "\n",
        "  llm_chain = LLMChain(prompt=prompt, llm=llm)\n",
        "  ret = llm_chain.run(trial_info=trial_info, query=query)\n",
        "  return ret\n",
        "\n"
      ],
      "metadata": {
        "id": "BHY3maoYVhLl"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "def run_HF_loop(df, repo, model_name):\n",
        "\n",
        "  # initialize the models\n",
        "  llm = HuggingFaceEndpoint(\n",
        "    repo_id = repo, temperature=0.1\n",
        "  )\n",
        "\n",
        "  prompt = generate_hf_prompt_template()\n",
        "\n",
        "  for idx, row in tqdm(final_df.iterrows()):\n",
        "    response = run_single_HF_query(row, prompt, llm)\n",
        "    df.loc[idx, model_name] = response\n",
        "    if idx % 10 == 0:\n",
        "      print(f\"\\nProcessed {idx} rows\")\n",
        "\n",
        "  return df"
      ],
      "metadata": {
        "id": "BZdjKp2wU12l"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "response_df = run_HF_loop(response_df.copy(), repo = \"mistralai/Mistral-7B-Instruct-v0.2\", model_name = \"Mistral-7B-Instruct-v0.2\")"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "hYH3PwD4WkC0",
        "outputId": "aedd8b42-7fc6-45f5-8e83-c1d551a2f198"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Token will not been saved to git credential helper. Pass `add_to_git_credential=True` if you want to set the git credential as well.\n",
            "Token is valid (permission: read).\n",
            "Your token has been saved to /root/.cache/huggingface/token\n",
            "Login successful\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "1it [00:01,  1.43s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 0 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "11it [00:51,  5.08s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 10 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "21it [01:31,  3.98s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 20 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "31it [02:14,  3.87s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 30 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "41it [02:53,  4.58s/it]"
          ]
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "Processed 40 rows\n"
          ]
        },
        {
          "output_type": "stream",
          "name": "stderr",
          "text": [
            "50it [03:29,  4.20s/it]\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "response_df.head()"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 553
        },
        "id": "f4mHesglXdas",
        "outputId": "054e7122-6da2-4c63-dd8b-398efa465e25"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "execute_result",
          "data": {
            "text/plain": [
              "         NCTId                                         BriefTitle  \\\n",
              "0  NCT05803096  Self-Administered Nitrous Oxide (SANO) During ...   \n",
              "1  NCT02220894  Study of Pembrolizumab (MK-3475) Versus Platin...   \n",
              "2  NCT02128724       Palliative Thoracic Radiotherapy Plus BKM120   \n",
              "3  NCT03557658  Safety and Efficacy of Bexagliflozin in Subjec...   \n",
              "4  NCT01438476  Postoperative Thoracic Epidural Analgesia Vers...   \n",
              "\n",
              "                                   InclusionCriteria  \\\n",
              "0  * Biological male\\n* Aged 18 to 85 years\\n* Sc...   \n",
              "1  :\\n\\n* Histologically- or cytologically-confir...   \n",
              "2  * Evidence of histologically confirmed NSCLC o...   \n",
              "3  o meet the following criteria to be eligible f...   \n",
              "4  1. Patients undergoing liver and/or pancreatic...   \n",
              "\n",
              "                                   ExclusionCriteria  \\\n",
              "0  * Perioral facial hair impeding good mask seal...   \n",
              "1  :\\n\\n* Histologically- or cytologically-confir...   \n",
              "2  * Previous chemotherapy or biological therapy ...   \n",
              "3  o meet the following criteria to be eligible f...   \n",
              "4  1. Evidence of severe uncontrolled systemic di...   \n",
              "\n",
              "                                        BriefSummary  \\\n",
              "0  Transrectal prostate biopsy is a commonly perf...   \n",
              "1  In this study, participants with programmed ce...   \n",
              "2  This study will test whether a drug called BKM...   \n",
              "3  The purpose of this study is to examine the dr...   \n",
              "4  The goal of this clinical research study is to...   \n",
              "\n",
              "                                          Conditions       StudyType  \\\n",
              "0  Prostate Disease, Malignancy, Benign Prostatic...  INTERVENTIONAL   \n",
              "1                       Non-small Cell Lung Cancer,   INTERVENTIONAL   \n",
              "2                   Carcinoma, Non-Small-Cell Lung,   INTERVENTIONAL   \n",
              "3                          Type2 Diabetes Mellitus,   INTERVENTIONAL   \n",
              "4                  Liver Cancer, Pancreatic Cancer,   INTERVENTIONAL   \n",
              "\n",
              "                                       Interventions  \\\n",
              "0          Self-Administered Nitrous Oxide, Oxygen,    \n",
              "1  pembrolizumab, carboplatin, paclitaxel, pemetr...   \n",
              "2                                           BKM120,    \n",
              "3                                    Bexagliflozin,    \n",
              "4  Intravenous Patient-Controlled Analgesia (IVPC...   \n",
              "\n",
              "                                     PrimaryOutcomes  \\\n",
              "0  Post-biopsy Pain (VAS-P), Post-biopsy Anxiety ...   \n",
              "1  Overall Survival (OS) in Participants With a T...   \n",
              "2  Dose Escalation Analysis: Number of DLTs Obser...   \n",
              "3  Cmax (Maximum Observed Plasma Concentration), ...   \n",
              "4                    Postoperative Pain Experience,    \n",
              "\n",
              "                                    BaselineMeasures  \\\n",
              "0  Age, Continuous, Sex: Female, Male, Race/Ethni...   \n",
              "1  Age, Continuous, Sex: Female, Male, Race (NIH/...   \n",
              "2  Age, Continuous, Sex: Female, Male, Race and E...   \n",
              "3  Age, Continuous, Sex: Female, Male, Ethnicity ...   \n",
              "4  Age, Categorical, Age, Continuous, Sex: Female...   \n",
              "\n",
              "                                       gpt-3.5-turbo  \\\n",
              "0  Age, Gender, Body Mass Index (BMI), Previous h...   \n",
              "1  Age, Gender, Race, ECOG Performance Status, Sm...   \n",
              "2  Age, Gender, Smoking history, Performance stat...   \n",
              "3  Age, Gender, Weight, Height, BMI, Blood Pressu...   \n",
              "4  Age, Gender, Body Mass Index, Smoking Status, ...   \n",
              "\n",
              "                                  gpt-4-0125-preview  \\\n",
              "0  Age, gender, race/ethnicity, body mass index (...   \n",
              "1  Age, sex, race/ethnicity, smoking history, Eas...   \n",
              "2  Age, sex, race/ethnicity, smoking history, per...   \n",
              "3  Age, sex, body mass index (BMI), duration of T...   \n",
              "4  Age, sex, body mass index (BMI), type of surge...   \n",
              "\n",
              "                            Mistral-7B-Instruct-v0.2  \n",
              "0  1. Age\\n  2. Body Mass Index (BMI)\\n  3. Prost...  \n",
              "1  1. Age\\n  2. Sex\\n  3. Eastern Cooperative Onc...  \n",
              "2  1. Age\\n  2. Gender\\n  3. Weight\\n  4. Height\\...  \n",
              "3  1. Body Weight,\\n  2. Height,\\n  3. Serum Crea...  \n",
              "4  1. Age,\\n  2. Gender,\\n  3. Body Mass Index (B...  "
            ],
            "text/html": [
              "\n",
              "  <div id=\"df-48886af3-59ca-4233-a206-b48ded6bf9f6\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>NCTId</th>\n",
              "      <th>BriefTitle</th>\n",
              "      <th>InclusionCriteria</th>\n",
              "      <th>ExclusionCriteria</th>\n",
              "      <th>BriefSummary</th>\n",
              "      <th>Conditions</th>\n",
              "      <th>StudyType</th>\n",
              "      <th>Interventions</th>\n",
              "      <th>PrimaryOutcomes</th>\n",
              "      <th>BaselineMeasures</th>\n",
              "      <th>gpt-3.5-turbo</th>\n",
              "      <th>gpt-4-0125-preview</th>\n",
              "      <th>Mistral-7B-Instruct-v0.2</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>NCT05803096</td>\n",
              "      <td>Self-Administered Nitrous Oxide (SANO) During ...</td>\n",
              "      <td>* Biological male\\n* Aged 18 to 85 years\\n* Sc...</td>\n",
              "      <td>* Perioral facial hair impeding good mask seal...</td>\n",
              "      <td>Transrectal prostate biopsy is a commonly perf...</td>\n",
              "      <td>Prostate Disease, Malignancy, Benign Prostatic...</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>Self-Administered Nitrous Oxide, Oxygen,</td>\n",
              "      <td>Post-biopsy Pain (VAS-P), Post-biopsy Anxiety ...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Race/Ethni...</td>\n",
              "      <td>Age, Gender, Body Mass Index (BMI), Previous h...</td>\n",
              "      <td>Age, gender, race/ethnicity, body mass index (...</td>\n",
              "      <td>1. Age\\n  2. Body Mass Index (BMI)\\n  3. Prost...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>NCT02220894</td>\n",
              "      <td>Study of Pembrolizumab (MK-3475) Versus Platin...</td>\n",
              "      <td>:\\n\\n* Histologically- or cytologically-confir...</td>\n",
              "      <td>:\\n\\n* Histologically- or cytologically-confir...</td>\n",
              "      <td>In this study, participants with programmed ce...</td>\n",
              "      <td>Non-small Cell Lung Cancer,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>pembrolizumab, carboplatin, paclitaxel, pemetr...</td>\n",
              "      <td>Overall Survival (OS) in Participants With a T...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Race (NIH/...</td>\n",
              "      <td>Age, Gender, Race, ECOG Performance Status, Sm...</td>\n",
              "      <td>Age, sex, race/ethnicity, smoking history, Eas...</td>\n",
              "      <td>1. Age\\n  2. Sex\\n  3. Eastern Cooperative Onc...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>NCT02128724</td>\n",
              "      <td>Palliative Thoracic Radiotherapy Plus BKM120</td>\n",
              "      <td>* Evidence of histologically confirmed NSCLC o...</td>\n",
              "      <td>* Previous chemotherapy or biological therapy ...</td>\n",
              "      <td>This study will test whether a drug called BKM...</td>\n",
              "      <td>Carcinoma, Non-Small-Cell Lung,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>BKM120,</td>\n",
              "      <td>Dose Escalation Analysis: Number of DLTs Obser...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Race and E...</td>\n",
              "      <td>Age, Gender, Smoking history, Performance stat...</td>\n",
              "      <td>Age, sex, race/ethnicity, smoking history, per...</td>\n",
              "      <td>1. Age\\n  2. Gender\\n  3. Weight\\n  4. Height\\...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>NCT03557658</td>\n",
              "      <td>Safety and Efficacy of Bexagliflozin in Subjec...</td>\n",
              "      <td>o meet the following criteria to be eligible f...</td>\n",
              "      <td>o meet the following criteria to be eligible f...</td>\n",
              "      <td>The purpose of this study is to examine the dr...</td>\n",
              "      <td>Type2 Diabetes Mellitus,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>Bexagliflozin,</td>\n",
              "      <td>Cmax (Maximum Observed Plasma Concentration), ...</td>\n",
              "      <td>Age, Continuous, Sex: Female, Male, Ethnicity ...</td>\n",
              "      <td>Age, Gender, Weight, Height, BMI, Blood Pressu...</td>\n",
              "      <td>Age, sex, body mass index (BMI), duration of T...</td>\n",
              "      <td>1. Body Weight,\\n  2. Height,\\n  3. Serum Crea...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>NCT01438476</td>\n",
              "      <td>Postoperative Thoracic Epidural Analgesia Vers...</td>\n",
              "      <td>1. Patients undergoing liver and/or pancreatic...</td>\n",
              "      <td>1. Evidence of severe uncontrolled systemic di...</td>\n",
              "      <td>The goal of this clinical research study is to...</td>\n",
              "      <td>Liver Cancer, Pancreatic Cancer,</td>\n",
              "      <td>INTERVENTIONAL</td>\n",
              "      <td>Intravenous Patient-Controlled Analgesia (IVPC...</td>\n",
              "      <td>Postoperative Pain Experience,</td>\n",
              "      <td>Age, Categorical, Age, Continuous, Sex: Female...</td>\n",
              "      <td>Age, Gender, Body Mass Index, Smoking Status, ...</td>\n",
              "      <td>Age, sex, body mass index (BMI), type of surge...</td>\n",
              "      <td>1. Age,\\n  2. Gender,\\n  3. Body Mass Index (B...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-48886af3-59ca-4233-a206-b48ded6bf9f6')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-48886af3-59ca-4233-a206-b48ded6bf9f6 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-48886af3-59ca-4233-a206-b48ded6bf9f6');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-948f2429-5835-405c-a858-20aadcf281b2\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-948f2429-5835-405c-a858-20aadcf281b2')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-948f2429-5835-405c-a858-20aadcf281b2 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "dataframe",
              "variable_name": "response_df",
              "summary": "{\n  \"name\": \"response_df\",\n  \"rows\": 50,\n  \"fields\": [\n    {\n      \"column\": \"NCTId\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"NCT01560637\",\n          \"NCT01186939\",\n          \"NCT01552694\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BriefTitle\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension\",\n          \"An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS)\",\n          \"Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"InclusionCriteria\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"* Participated in United Therapeutics Study TDE-PH-310\\n* All women of childbearing potential (WOCBP) must have practiced true abstinence from intercourse when it was in line with their preferred and usual lifestyle or used 2 different forms of highly effective contraception for the duration of the study and for at least 30 days after discontinuing study medication.\\n* Males who participated in the study must have used a condom during the length of the study and for at least 48 hours after their last dose of study medication.\",\n          \"* Participants were considered eligible if they had been randomized to azacitidine treatment in the primary study and were receiving azacitidine at the time of study closure, had completed 12 months of treatment and observation in the primary study, and had signed the informed consent document for the extension phase of the study.\\n* See study: AZA PH GL 2003 CL 001 for a list of inclusion criteria for the primary study.\",\n          \"* 18-65 yr old HIV infected men and women.\\n* Stable (at least the past 6 months) on combined antiretroviral therapy (cART).\\n* Stable immune (\\\\> 300 CD4+ T-cells/\\u00b5L) and virologic (\\\\< 50 copies HIV RNA/mL) status.\\n* Insulin resistant/impaired glucose tolerance (fasting glucose 100-125mg/dL, or 2-hr glucose 140-200mg/dL or fasting HOMA-IR= 2.5-6.0).\\n* Waist circumference \\\\> 102 cm (men), \\\\> 88 cm (women).\\n* BMI \\\\> 20 kg/m2.\\n* Fasting hypertriglyceridemia \\\\> 150 mg/dL.\\n* Low HDL-cholesterol (\\\\< 40 mg/dL in men or \\\\< 50 mg/dL in women).\\n* Platelet count \\\\> 30,000/mm3.\\n* Absolute neutrophil count \\\\> 750/mm3.\\n* Transaminases \\\\< 2.5x the upper limit of normal.\\n* Long-term non-progressors (not taking anti-HIV medications) are not eligible.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"ExclusionCriteria\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"* The subject was pregnant or lactating.\\n* The subject had received infused or inhaled prostacyclin therapy for 29 days or more.\\n* The subject was prematurely discontinued from TDE-PH-310 for reasons other than a clinical worsening event.\\n* The subject developed a concurrent illness or condition during the conduct of TDE-PH-310 which, in the opinion of the Investigator, would represent a risk to their overall health if they enrolled in this study.\",\n          \"* None specific to the extension phase of the study\\n* See study: AZA PH GL 2003 CL 001 for a list of exclusion criteria for the primary study.\",\n          \"* Diabetes (T2DM, IDDM or diabetic ketoacidosis) or taking any glucose-lowering medication (e.g., insulin, TZDs, metformin, sulfonylurea).\\n* Any agent that might artifactually alter glycemic control (e.g., glucocorticoids, megace, rhGH, GH-secretagogue, testosterone derivatives, creatine monohydrate, chromium picolinate, AA/protein supplements, medium- or long-chain fatty acids) during 6 months prior to or during enrollment.\\n* History of serious CV disease. NYHA Functional Class III or IV (e.g., recent MI, unstable angina, edema, CHF, CAD, CABG, stroke, resting hypertension \\\\> 160/95 mmHg), irregular heart rhythm, resting ST-segment depression \\\\> 1mm). Treatment with medications for CV condition (e.g., \\u03b1- or \\u00df-blockers). Some BP-lowering medications (Ca++channel blocker, diuretic, or ACE inhibitor) are permitted.\\n* Moderate to severe renal insufficiency. Serum creatinine \\\\> 1.7 mg/dL (men) \\\\> 1.5 mg/dL (women).\\n* Plan or anticipate a change in anti-HIV medications during the study.\\n* Lipid-lowering medications are permitted (fibrate or statin or niacin), but must be stable on that agent for at least 6 months prior to enrollment. Lipid-lowering agents cannot be started during the treatment period.\\n* Chronic hepatitis B (HBV-surface antigen positive). Active hepatitis C (detectable Hep C RNA).\\n* Positive urine drug test for opiates, methamphetamine, heroin, cocaine. Active substance abuse that the MD-scientist believes may compromise safety, compliance, interfere with study drug or data interpretation.\\n* Hematocrit \\\\< 34% in men or \\\\< 25% in women with symptoms (fatigue, \\\"tired-legs\\\", shortness of breath). Hemoglobin \\\\< 10 gm/dL with symptoms.\\n* Pregnant or nursing mothers. Women must agree to use an acceptable form of birth control during the study. If using birth control pills-must be stable on this medication for at least 6 months prior to enrollment.\\n* Active malignancy or treatment with chemotherapeutic agents or radiation therapy or any cytokine or anti-cytokine therapy during 6 months prior to enrollment.\\n* History of pancreatitis\\n* \\\\> 10% unintentional weight loss during the 6 months prior to enrollment.\\n* Reduced cognitive function/unable to provide voluntary informed consent. Prisoners are excluded.\\n* Blinded investigational drugs for 3 months prior to enrollment that will not be unblinded before enrollment.\\n* Nausea, vomiting, diarrhea (\\\\> 4 loose stools/day) that are unresponsive to treatment.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BriefSummary\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"This study is an international, multi-center, open-label study designed to provide oral treprostinil (UT-15C) to eligible subjects with pulmonary arterial hypertension who have completed the TDE-PH-310 study. The purpose of this study is to assess the long-term safety of UT-15C and to assess the effects of long-term treatment with UT-15C on exercise capacity.\",\n          \"At the conclusion of study AZA PH GL 2003 CL 001 (NCT00071799), eligible participants could be enrolled in an optional extension phase in order to continue treatment with azacitidine until it became commercially available; the continued treatment was for ethical and safety reasons only and not to provide additional efficacy data.\",\n          \"People living with human immunodeficiency virus infection (HIV) have 2-4fold greater risk for developing diabetes and heart disease than the general population. They need safe and effective treatments that reduce the risk for developing diabetes and heart disease, and improve their quality of life. This project will explore whether a new anti-diabetes medication (Januvia) with a novel mechanism of action reduces inflammation, and improves blood vessel function in HIV infected men and women with several risk factors for developing cardiovascular disease.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Conditions\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 48,\n        \"samples\": [\n          \"Metabolic Syndrome X, \",\n          \"Type 2 Diabetes Mellitus, \",\n          \"Hypertension, Hyperlipidemia, Diabetes, \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"StudyType\",\n      \"properties\": {\n        \"dtype\": \"category\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"INTERVENTIONAL\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Interventions\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"UT-15C (treprostinil diolamine), \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"PrimaryOutcomes\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"Number of Adverse Events, \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"BaselineMeasures\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 46,\n        \"samples\": [\n          \"Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, BMI, Arterial hypertension (AH) duration, Hypertension grade, Chronic heart failure (CHF) NYHA Class I, Prior therapy for arterial hypertension, Smoking history, Alcohol history, \"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"gpt-3.5-turbo\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"Age, Gender, Weight, Height, Body Mass Index, Pulmonary Arterial Hypertension Functional Class, Six-Minute Walk Distance, Borg Dyspnea Score, Hemodynamics (e.g., Right Atrial Pressure, Cardiac Output), World Health Organization Functional Class, Use of Concomitant Medications\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"gpt-4-0125-preview\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"Age, sex, race, body mass index (BMI), baseline 6-minute walk distance (6MWD), World Health Organization (WHO) functional class, duration of pulmonary arterial hypertension, prior pulmonary arterial hypertension therapy, right heart catheterization parameters (mean pulmonary artery pressure, pulmonary vascular resistance, cardiac output), echocardiographic parameters (right ventricular size and function, tricuspid annular plane systolic excursion), N-terminal pro b-type natriuretic peptide (NT-proBNP) levels, liver function tests, renal function tests, hemoglobin levels, platelet count\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Mistral-7B-Instruct-v0.2\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 50,\n        \"samples\": [\n          \"1. Demographic data (age, gender, weight, height)\\n2. Pulmonary arterial hypertension diagnosis and etiology\\n3. New York Heart Association functional class\\n4. 6-minute walk test distance\\n5. Cardiac biomarkers (NT-proBNP, BNP)\\n6. Echocardiography data (left ventricular ejection fraction, right ventricular function, pulmonary artery pressure)\\n7. Brain natriuretic peptide (BNP)\\n8. N-terminal pro-B-type natriuretic peptide (NT-proBNP)\\n9. Hemoglobin\\n10. Hematocrit\\n11. Platelet count\\n12. Creatinine clearance\\n13. Liver function tests (ALT, AST, ALT/AST ratio)\\n14. Electrocardiogram (ECG) findings\\n15. Resting heart rate\\n16. Resting blood pressure\\n17. Current medications and dosages\\n18. Smoking status\\n19. Alcohol consumption\\n20. Physical activity level.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}"
            }
          },
          "metadata": {},
          "execution_count": 93
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import random\n",
        "import inspect\n",
        "import textwrap\n",
        "\n",
        "# initialize the models\n",
        "chat_prompt = generate_openai_prompt_template()\n",
        "\n",
        "# randomly select a row from the dataframe\n",
        "idx = random.randint(0, len(response_df) - 1)\n",
        "row = response_df.iloc[idx]\n",
        "\n",
        "prompt = single_openai_prompt(row, chat_prompt)\n",
        "\n",
        "print(textwrap.dedent(f\"Prompt: \\n System Message: {prompt[0].content} \\n Human Message: {prompt[1].content}\"))\n",
        "print(f\"Baseline Measures: {row.BaselineMeasures}\")\n",
        "print(f\"GPT 3.5 Response: {row['gpt-3.5-turbo']}\")\n",
        "print(f\"GPT 4 Response: {row['gpt-4-0125-preview']}\")\n",
        "print(f\"Mistral-7B-Instruct-v0.2 Response: {row['Mistral-7B-Instruct-v0.2']}\")\n",
        "\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "w1xnydaJfcRE",
        "outputId": "89aed063-d12c-41ef-8051-f6de8b0305f4"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Prompt: \n",
            " System Message: You are a helpful assistant and expert in clinical domain and clinical trial design. Answer the question based on the context below and your knowledge on clinical trials and clinical domain \n",
            " Human Message: \n",
            "\n",
            "    Context: \n",
            "    Title- Study of Pembrolizumab (MK-3475) Versus Platinum-Based Chemotherapy for Participants With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (MK-3475-042/KEYNOTE-042)\n",
            "Brief Summary- In this study, participants with programmed cell death ligand 1 (PD-L1)-positive non-small cell lung cancer (NSCLC) will be randomized to receive single agent pembrolizumab for up to 35 treatments or standard of care (SOC) platinum-based chemotherapy (carboplatin + paclitaxel or carboplatin + pemetrexed for 4 to 6 21-day cycles). Participants in the platinum-based chemotherapy arms with non-squamous tumor histologies may receive pemetrexed maintenance therapy after the 4 to 6 cycles of chemotherapy. The primary study hypothesis is that pembrolizumab prolongs overall survival (OS) compared to SOC chemotherapy.\n",
            "Condition- Non-small Cell Lung Cancer, \n",
            "Intervention- pembrolizumab, carboplatin, paclitaxel, pemetrexed, \n",
            "Outcome- Overall Survival (OS) in Participants With a Tumor Proportion Score (TPS) of 50%, Overall Survival (OS) in Participants With a Tumor Proportion Score (TPS) of 20%, Overall Survival (OS) in Participants With a Tumor Proportion Score (TPS) of 1%, \n",
            "\n",
            "    Question: \n",
            "    Return a list of probable baseline features (seperated by comma, without itemizing or bullet points) that needs to  be measured before the trial starts and in each follow up visits. These baseline  features are usually found in Table 1 of a trial related publications. Don't give any additional explanations.\n",
            "\n",
            "    Answer: \n",
            "\n",
            "\n",
            "Baseline Measures: Age, Continuous, Sex: Female, Male, Race (NIH/OMB), Eastern Cooperative Oncology Group (ECOG) Performance Status (PS), Programmed Cell Death-Ligand 1 (PD-L1) Tumor Status, Tumor Histology, \n",
            "GPT 3.5 Response: Age, Gender, Race, ECOG Performance Status, Smoking History, Tumor Stage, Histology, PD-L1 Expression Level, Presence of Brain Metastases, Presence of Liver Metastases, Presence of Bone Metastases\n",
            "GPT 4 Response: Age, sex, race/ethnicity, smoking history, Eastern Cooperative Oncology Group (ECOG) performance status, tumor histology, PD-L1 expression level (TPS), stage of cancer, prior treatments for NSCLC, presence of brain metastases, renal function, liver function, baseline blood counts\n",
            "Mistral-7B-Instruct-v0.2 Response: 1. Age\n",
            "  2. Sex\n",
            "  3. Eastern Cooperative Oncology Group (ECOG) performance status\n",
            "  4. PD-L1 tumor proportion score (TPS)\n",
            "  5. Tumor histology\n",
            "  6. Tumor stage\n",
            "  7. Smoking status\n",
            "  8. Weight\n",
            "  9. Height\n",
            "  10. Laboratory values (e.g. hemoglobin, neutrophil count, platelet count, creatinine, aspartate aminotransferase, alanine aminotransferase, total bilirubin, alkaline phosphatase, albumin, calcium, sodium, potassium, chloride, glucose, total protein)\n",
            "  11. Renal function (e.g. creatinine clearance)\n",
            "  12. Liver function (e.g. bilirubin, ALT, AST)\n",
            "  13. Cardiac function (e.g. ejection fraction, left ventricular end diastolic diameter)\n",
            "  14. Brain metastases (yes/no)\n",
            "  15. Prior chemotherapy and radiation therapy (yes/no, type and dose)\n",
            "  16. Prior immunotherapy (yes/no, type and dose)\n",
            "  17. Other concurrent medications (yes/no, name and dose)\n",
            "  18. Pregnancy status (yes/no)\n",
            "  19. Karnofsky Performance Status (KPS)\n",
            "  20. Blood type.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "response_df.to_csv('response_df.csv', index=False, header=True)"
      ],
      "metadata": {
        "id": "yIyKJawWjwFG"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "g_jeBqfUGbqY"
      },
      "source": [
        "## Evaluate Score\n",
        "Score 1: BERTScore based on contextual similarity:\n",
        "*   Link 1 - https://huggingface.co/spaces/evaluate-metric/bertscore\n",
        "*   Link 2 - https://github.com/Tiiiger/bert_score#readme\n",
        "\n",
        "\n",
        "  "
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "from evaluate import load\n",
        "bertscore = load(\"bertscore\")\n",
        "\n",
        "idx = random.randint(0, len(response_df) - 1)\n",
        "row = response_df.iloc[idx]\n",
        "\n",
        "reference = row['BaselineMeasures']\n",
        "response_gpt_3_5_turbo = row['gpt-3.5-turbo']\n",
        "response_gpt_4_0125_preview = row['gpt-4-0125-preview']\n",
        "response_mistral_7b_instruct_v0_2 = row['Mistral-7B-Instruct-v0.2']\n",
        "\n",
        "print(f\"Reference: {reference}\\n\")\n",
        "\n",
        "print(f\"GPT 3.5 Response: {response_gpt_3_5_turbo}\")\n",
        "results = bertscore.compute(predictions=[response_gpt_3_5_turbo], references=[reference], model_type=\"distilbert-base-uncased\")\n",
        "print(f\"BERTScore of GPT 3.5 Response: {results}\\n\")\n",
        "\n",
        "print(f\"GPT 4 Response: {response_gpt_4_0125_preview}\")\n",
        "results = bertscore.compute(predictions=[response_gpt_4_0125_preview], references=[reference], model_type=\"distilbert-base-uncased\")\n",
        "print(f\"BERTScore of GPT 4 Response: {results}\\n\")\n",
        "\n",
        "print(f\"Mistral-7B-Instruct-v0.2 Response: {response_mistral_7b_instruct_v0_2}\")\n",
        "results = bertscore.compute(predictions=[response_mistral_7b_instruct_v0_2], references=[reference], model_type=\"distilbert-base-uncased\")\n",
        "print(f\"BERTScore of Mistral-7B-Instruct-v0.2 Response: {results}\")\n",
        "\n"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "52gnlseT4X9I",
        "outputId": "de56eae3-2c62-4be6-ce18-189b684ddef7"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Reference: Age, Categorical, Age, Continuous, Sex: Female, Male, Ethnicity (NIH/OMB), Race/Ethnicity, Customized, Region of Enrollment, Type of Adjuvant Endocrine Therapy, Breast Cancer Stage, Ovarian Suppression, \n",
            "\n",
            "GPT 3.5 Response: Age, Time since breast cancer diagnosis, Hormonal therapy regimen, Previous experience with group therapy, Baseline symptoms related to hormonal therapy, Baseline distress levels\n",
            "BERTScore of GPT 3.5 Response: {'precision': [0.8298296928405762], 'recall': [0.7879796028137207], 'f1': [0.8083633780479431], 'hashcode': 'distilbert-base-uncased_L5_no-idf_version=0.3.12(hug_trans=4.38.2)'}\n",
            "\n",
            "GPT 4 Response: Age, gender, race/ethnicity, education level, marital status, employment status, breast cancer stage at diagnosis, type of hormonal therapy, duration of hormonal therapy use, previous cancer treatments (e.g., chemotherapy, radiation), menopausal status, comorbid conditions, baseline symptom severity, baseline medication adherence, baseline psychological distress levels, quality of life measures\n",
            "BERTScore of GPT 4 Response: {'precision': [0.8306291103363037], 'recall': [0.8403099179267883], 'f1': [0.835441529750824], 'hashcode': 'distilbert-base-uncased_L5_no-idf_version=0.3.12(hug_trans=4.38.2)'}\n",
            "\n",
            "Mistral-7B-Instruct-v0.2 Response: 1. Age\n",
            "  2. Menopausal status\n",
            "  3. Type of breast cancer\n",
            "  4. Stage of breast cancer\n",
            "  5. Hormonal therapy regimen\n",
            "  6. Adherence to hormonal therapy\n",
            "  7. Symptoms related to hormonal therapy or breast cancer\n",
            "  8. Distress levels\n",
            "  9. Quality of life\n",
            "  10. Demographic information (ethnicity, education, income, etc.)\n",
            "  11. Psychological status (anxiety, depression, etc.)\n",
            "  12. Social support\n",
            "  13. Health insurance status\n",
            "  14. Medical history (comorbidities, etc.)\n",
            "  15. Current medications (other than hormonal therapy)\n",
            "  16. Body Mass Index (BMI)\n",
            "  17. Smoking status\n",
            "  18. Alcohol consumption\n",
            "  19. Physical activity levels\n",
            "  20. Dietary habits.\n",
            "BERTScore of Mistral-7B-Instruct-v0.2 Response: {'precision': [0.7043319940567017], 'recall': [0.7885724306106567], 'f1': [0.7440754175186157], 'hashcode': 'distilbert-base-uncased_L5_no-idf_version=0.3.12(hug_trans=4.38.2)'}\n"
          ]
        }
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "Score 2 - GPT 4 as an evaluator"
      ],
      "metadata": {
        "id": "Xsvbj8-B78Ac"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# prompt: write code to ask OpenAI GPT-4 model to score similarity between reference and each response\n",
        "\n",
        "from openai import OpenAI\n",
        "client = OpenAI()\n",
        "\n",
        "prompt = (\n",
        "    f\"We are evaluating three AI models' responses based on their similarity to a reference string.\\n\"\n",
        "    f\"Reference string: {reference}\\n\"\n",
        "    f\"Model 1 Response: {response_gpt_3_5_turbo}\\n\"\n",
        "    f\"Model 2 Response: {response_gpt_4_0125_preview}\\n\"\n",
        "    f\"Model 3 Response: {response_mistral_7b_instruct_v0_2}\\n\"\n",
        "    f\"Make sure to correctly identify each feature in the reference string first. Not all comma-separated values are features.\"\n",
        "    f\"For example - [Age, Continuous, Age, Categorical, Sex: Male, Female, Ethnicity] in this list features are [Age, Sex, Ethnicity.]\"\n",
        "    f\"In reference feature list, avoid considering data types (categorical, continuous), sub-category names, measurement metric names etc. as feature names.\"\n",
        "    f\"For each model response, score its similarity to the reference string on a scale of 0 to 1, where 0 is completely dissimilar and 1 is perfectly similar. Also calculate precision, recall, F1 scores.\\n\"\n",
        "    f\"Let's think step by step. First step is curate a list of actual reference features. Then second step is to match each model's response to this curated feature list.\"\n",
        "    f\"In this second step, make sure you take underlying semantic and contexual similarity into account.\"\n",
        "    f\"List features that match exactly, that matches partially based on contextuality/semantics, that are present in reference but not in response, and that are present in response but no in reference.\"\n",
        "    f\"Return the scores in the following format (show decimal values too, not only fractions):\\n\"\n",
        "    f\"Model 1 Score: \\n\"\n",
        "    f\"Model 2 Score: \\n\"\n",
        "    f\"Model 3 Score: \"\n",
        ")\n",
        "\n",
        "completion = client.chat.completions.create(\n",
        "  model=\"gpt-4-0125-preview\",\n",
        "  messages=[\n",
        "    {\"role\": \"system\",\n",
        "     \"content\": \"You are a helpful assistant and expert in clinical domain and clinical trial design.\\\n",
        "  Answer the question based on your knowledge on clinical trials and clinical domain\"},\n",
        "    {\"role\": \"user\", \"content\": prompt}\n",
        "  ]\n",
        ")\n"
      ],
      "metadata": {
        "id": "W2cZi0Ac78Jj"
      },
      "execution_count": null,
      "outputs": []
    },
    {
      "cell_type": "code",
      "source": [
        "print(completion.choices[0].message.content)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "8Ra7gQzW9vCT",
        "outputId": "b5606f19-9461-4726-ac89-b8026e5ed2b6"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "To properly evaluate the similarity between the AI models' responses and the reference string, let's first elucidate the reference features list. \n",
            "\n",
            "### Reference Features List\n",
            "1. Age\n",
            "2. Sex\n",
            "3. Ethnicity (NIH/OMB)\n",
            "4. Race/Ethnicity\n",
            "5. Region of Enrollment\n",
            "6. Type of Adjuvant Endocrine Therapy\n",
            "7. Breast Cancer Stage\n",
            "8. Ovarian Suppression\n",
            "\n",
            "Given this list, we can now assess each model based on the exact match, partial/contextual match, and differences.\n",
            "\n",
            "### Model 1 Evaluation\n",
            "- **Exact Matches:** Age\n",
            "- **Partial/Contextual Matches:** Hormonal therapy regimen (Type of Adjuvant Endocrine Therapy), Baseline distress levels (could be considered under Ovarian Suppression if interpreted as a type of symptom or effect)\n",
            "- **Not in Reference:** Time since breast cancer diagnosis, Previous experience with group therapy, Baseline symptoms related to hormonal therapy\n",
            "- **Missing from Response:** Sex, Ethnicity (NIH/OMB), Race/Ethnicity, Region of Enrollment, Breast Cancer Stage\n",
            "\n",
            "### Model 2 Evaluation\n",
            "- **Exact Matches:** Age, Sex, Race/Ethnicity\n",
            "- **Partial/Contextual Matches:** Type of hormonal therapy (Type of Adjuvant Endocrine Therapy), Breast cancer stage at diagnosis (Breast Cancer Stage), Baseline psychological distress levels (could relate to Ovarian Suppression in the context of symptoms)\n",
            "- **Not in Reference:** Gender (considered under sex), Education level, Marital status, Employment status, Duration of hormonal therapy use, Previous cancer treatments, Menopausal status, Comorbid conditions, Baseline symptom severity, Baseline medication adherence, Quality of life measures\n",
            "- **Missing from Response:** Ethnicity (NIH/OMB), Region of Enrollment, Ovarian Suppression\n",
            "\n",
            "### Model 3 Evaluation\n",
            "- **Exact Matches:** Age, Ethnicity (if \"Demographic information\" includes it)\n",
            "- **Partial/Contextual Matches:** Type of breast cancer (might imply Stage of Breast Cancer), Hormonal therapy regimen (Type of Adjuvant Endocrine Therapy), Symptoms related to hormonal therapy or breast cancer (could imply Ovarian Suppression), Distress levels (could imply Ovarian Suppression), Demographic information (Race/Ethnicity, if it includes both)\n",
            "- **Not in Reference:** Menopausal status, Adherence to hormonal therapy, Quality of life, Psychological status, Social support, Health insurance status, Medical history, Current medications, Body Mass Index (BMI), Smoking status, Alcohol consumption, Physical activity levels, Dietary habits\n",
            "- **Missing from Response:** Sex, Region of Enrollment\n",
            "\n",
            "### Scoring\n",
            "\n",
            "For simplicity, I'll aggregate the exact and partial matches as \"matches\" for calculating Precision, Recall, and F1 scores. This approximation is due to the limitations in assessing nuanced contextual relations solely through text.\n",
            "\n",
            "#### Model 1\n",
            "- **Precision** = Matches / (Matches + Not in Reference) = 2 / (2 + 3) = 0.4\n",
            "- **Recall** = Matches / (Matches + Missing from Response) = 2 / (2 + 5) = 0.2857\n",
            "- **F1 Score** = 2 * (Precision * Recall) / (Precision + Recall) = 2 * (0.4 * 0.2857) / (0.4 + 0.2857) = 0.3333\n",
            "- **Similarity Score** = 0.3333\n",
            "\n",
            "#### Model 2\n",
            "- **Precision** = 5 / (5 + 9) = 0.3571\n",
            "- **Recall** = 5 / (5 + 3) = 0.625\n",
            "- **F1 Score** = 2 * (0.3571 * 0.625) / (0.3571 + 0.625) = 0.4545\n",
            "- **Similarity Score** = 0.4545\n",
            "\n",
            "#### Model 3\n",
            "- **Precision** = 4 / (4 + 16) = 0.2\n",
            "- **Recall** = 4 / (4 + 4) = 0.5\n",
            "- **F1 Score** = 2 * (0.2 * 0.5) / (0.2 + 0.5) = 0.2857\n",
            "- **Similarity Score** = 0.2857\n",
            "\n",
            "### Summary:\n",
            "- **Model 1 Score:** Similarity = 0.3333, Precision = 0.4, Recall = 0.2857, F1 = 0.3333\n",
            "- **Model 2 Score:** Similarity = 0.4545, Precision = 0.3571, Recall = 0.625, F1 = 0.4545\n",
            "- **Model 3 Score:** Similarity = 0.2857, Precision = 0.2, Recall = 0.5, F1 = 0.2857\n",
            "\n",
            "Model 2 is the most similar to the reference list based on the calculated scores.\n"
          ]
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "7Lb3aRVwDeNn"
      },
      "outputs": [],
      "source": [
        "# LOOP CODE\n",
        "# from bert_score import BERTScorer\n",
        "# scores = []\n",
        "# for idx, row in response_df.iterrows():\n",
        "#   response = row['GPT_3.5_Turbo']\n",
        "#   reference = row['BaselineMeasures']\n",
        "#   scorer = BERTScorer(model_type='bert-base-uncased', lang='en')\n",
        "#   if not response or not reference or pd.isna(reference):\n",
        "#     scores.append(np.nan)\n",
        "#     continue\n",
        "#   P, R, F1 = scorer.score([response], [reference])\n",
        "#   scores.append(F1.mean().item())\n",
        "#   if idx % 10 == 0:\n",
        "#     print(f\"Processed {idx} rows\")\n",
        "# response_df['BERTScore'] = scores"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "**Issues**\n",
        "\n",
        "  Dataset Issues:\n",
        "  - Some trials doesn't report ANY baseline variable in the portal (but they list them in the publication)\n",
        "  - Some trials doesn't report ALL baseline variables in the portal (but they list them in the publication)\n",
        "  - Not all trial publications are accessible (behind paywall)\n",
        "  - Tracking publications one by one and manually download them and list out all baseline features is almost impossible for 1500 trials\n",
        "\n",
        "  Solution -->\n",
        "  - Show result for these ~1800 trials with whatever features reported in the portal and can be extracted using API\n",
        "  - Additionally show result for a smaller manually found and curated set (~10/20 studies per condition) - Can be used for RAG as well\n",
        "\n",
        "\n",
        "  Inference Issues:\n",
        "  - Inference with GPT-4 is extremely slow: both in case of baseline measure generation and scoring candidate responses (Does parallelization help here?)\n",
        "\n",
        "\n",
        "  Scoring Issues:\n",
        "  - How to write the optimal prompt for generating scores using GPT4?\n",
        "  - Which scores are we interested in?\n",
        "  - Which additional scores can we look at? (e.g. standard vector cosine similarity based on Clinical BERT encoding?)\n",
        "\n",
        "\n",
        "  Overall goals:\n",
        "  - List of tasks we want to benchmark and evaluate LLMs (e.g. list baseline measures, list exclusion criteria, list inclusion criteria) and ground truth for these?\n",
        "  - What should be the dataset we are planning to release?\n",
        "  - Examples of hallucinations in this scenario?\n",
        "  - Possible ways to trigger hallucination?\n"
      ],
      "metadata": {
        "id": "Cu1L38SiENs5"
      }
    },
    {
      "cell_type": "markdown",
      "source": [
        "Few Shot examples\n",
        "\n",
        "  - trial context + baseline measure\n",
        "  - trial evaluation\n",
        "\n",
        "Hand annotated examples 1 or 2\n",
        "\n"
      ],
      "metadata": {
        "id": "Cx6CaGWWF472"
      }
    }
  ],
  "metadata": {
    "accelerator": "GPU",
    "colab": {
      "gpuType": "V100",
      "machine_shape": "hm",
      "provenance": [],
      "authorship_tag": "ABX9TyPT2cqege9dpXbxIwaCduGd",
      "include_colab_link": true
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}